Catalog |
name |
Description |
price |
R-M1by-9123 |
(Z-DEVD)2-R110 |
(Z-DEVD)2-R110 is a substrate used in the measurement of caspase-3 and caspase-7 activity, particularly in enzyme-linked immunosorbent assays (ELISAs). The substrate is comprised of a caspase recognition sequence (Z-DEVD)2, which is connected to a fluorescent reporter group, R110.This type of substrate is frequently used in the field of cell biology and biochemistry to study the mechanisms of apoptosis, as well as for drug screening and assessment of caspase activity in various experimental settings. |
price> |
R-M1-9161 |
FITC-RVG29-Cys-PEG2K |
FITC-RVG29-Cys-PEG2K is a fluorescent labeled peptide peg reagent that can be used in fields such as drug delivery systems and biological imaging. |
price> |
R-M1-9162 |
Chol-PEG2000-VTAMEPGQ-K-FITC |
Chol-PEG2000-VTAMEPGQ-K-FITC/Cholesterol-PEG2K-VTAMEPGQ-K-FITC is a fluorescent labeled peptide PEG reagent that can be used in fields such as drug delivery systems and biological imaging. |
price> |
R-M1-9163 |
Chol-PEG2000-DSSDSSDSSDSSDSSDSS-K-FITC |
Chol-PEG2000-DSSDSSDSSDSSDSSDSS-K-FITC/ Chol-PEG2000-DSSDSSDSSDSSDSSDSS-K-FITC is a fluorescent labeled peptide PEG reagent that can be used in fields such as drug delivery systems and biological imaging. |
price> |
R-M2-9433 |
FITC-VHPKQHRC-PEG2K |
FITC-VHPKQHRC-PEG2K can be used in fluorescence microscopy to visualize cells, track cellular uptake, or study intracellular pathways.
The PEGylated peptide can enhance the delivery of therapeutics selectively to specific cells, especially when the peptide has cell-penetrating or receptor-targeting capabilities.
This conjugate can serve in various diagnostics and therapeutic settings, such as in assays using flow cytometry or as part of larger bioconjugates for therapeutic screening.
The hydrophilicity of PEG can aid in the circulation time of the conjugate in blood, thus improving the pharmacokinetics in potential therapeutic applications. |
price> |
R-M2-9435 |
Chol-PEG2K-CAQK-FITC |
Chol-PEG2K-CAQK-FITC/Cholesterol-PEG2K-CAQK-FITC can be applied to Fluorescent Labeling, Drug Delivery, Targeted Therapy.
Fluorescent Labeling: The FITC component makes this molecule useful for fluorescence microscopy or flow cytometry, useful for visualizing or sorting cells with specific traits.
Drug Delivery: The combination of cholesterol and PEG suggests applications in the incorporation of hydrophilic drugs into liposomal or micellar structures, improving drug solubility and biodistribution.
Targeted Therapy: The CAQK peptide sequence could mediate specific interactions with cells or tissues, potentially guiding drug delivery agents to their site of action. |
price> |
R-M2-9442 |
FITC-CPVLDLFRELLNELLEALKQKLK |
FITC-CPVLDLFRELLNELLEKQKKLK is a fluorescent peptide that can be used in fluorescence microscopy and flow cytometry. |
price> |
R-M2-9444 |
PEG2000-FITC-DITWDQLWDLMK |
The PEG2000-FITC-DITWDQLWDLMK conjugate likely has several practical applications, including:Cellular Studies,Biodistribution Studies,Immunological Research,Drug Delivery.
Cellular Studies: The compound can be used to study peptide uptake, localization, and interaction with cells using fluorescence microscopy or flow cytometry.
Biodistribution Studies: The PEG component may enhance the stability and half-life of the peptide in circulation, making it useful for long-term tracking in vivo.
Immunological Research: It can be used to develop assays or antibody responses, leveraging the FITC label for detection.
Drug Delivery: The PEGylation might improve the pharmacokinetic profile of therapeutic peptides, making them more effective as drugs. |
price> |
R-M2-9471 |
PEG2000-TFYGGRPKRNNFLRGIRSRGD-FITC |
PEG2000-TFYGGRPKRNNFLRGIRSRGD-FITC is a versatile and strategically designed bioconjugate that merges the benefits of polyethylene glycol, a bioactive peptide sequence with targeting capabilities, and a fluorescent label for visualization. Its potential applications in drug delivery, cancer treatment, tissue engineering, and biological research make it a valuable tool for both fundamental studies and therapeutic development. |
price> |
R-M2-9472 |
DMG-PEG2000-TFYGGRPKRNNFLRGIRSRGD-FITC |
DMG-PEG2000-TFYGGRPKRNNFLRGIRSRGD-FITC represents a sophisticated bioconjugate with multifaceted applications in targeted drug delivery, cancer therapy, tissue engineering, and biological research. The synergistic effect of each component — DMG for stabilization, PEG for solubility and circulation, the peptide for specific targeting, and FITC for visualization — makes this construct a valuable tool in both research and clinical settings. |
price> |